Thermo Fisher Scientific Pioneers Sustainability in Biologics Manufacturing with Plant-Based Bioprocessing Containers

Latest News

Thermo Fisher Scientific Inc., is advancing the sustainability of biologics therapy manufacturing by introducing plant-based materials for its single-use technology bioprocessing containers (BPCs). This innovative move replaces fossil fuel-derived materials with lower-carbon, biobased films, building on the company’s established Aegis™ and CX film offerings. This transition enables customers to reduce greenhouse gas (GHG) emissions while maintaining consistency in their BPCs.

The biobased films have received the International Sustainability and Carbon Certification (ISCC) PLUS, a prestigious certification for circular and biobased products. Starting early 2025, biopharma manufacturers can integrate these films into their systems, with the option to pre-purchase now. Thermo Fisher will also assist customers in tracking their carbon reduction achievements, aiding them in meeting sustainability targets.

“Biopharma manufacturers are focused on maximizing productivity, accelerating time-to-market, and generating efficiencies while improving the overall sustainability of their operations,” said Ray Mercier, president of Thermo Fisher’s single-use technologies business. “Our biobased films allow customers to reduce their environmental impact without having to validate new BPCs, helping them bring treatments to patients faster while also helping to protect the planet.”

Thermo Fisher also facilitates the recycling of BPCs, connecting customers with recyclers to convert used containers into high-quality plastic lumber. Since the program’s inception, approximately 400,000 pounds of plastic waste have been diverted from landfills or incineration, supporting biopharma manufacturers in achieving their sustainability goals.

Further demonstrating its commitment to sustainable practices, Thermo Fisher has earned an ISCC PLUS certification for manufacturing biobased resins used in its Nunc Cell Factory™ product line, which is integral in vaccine and biologics production.

“At Thermo Fisher, we pride ourselves on enabling our customers to make the world healthier, cleaner, and safer,” said Daniella Cramp, president of Thermo Fisher Scientific’s bioproduction business. “We are reengineering the way we design, produce, package, and ship our products to reduce the environmental impacts of our industry, without compromising the quality and performance our customers expect. Our biobased solutions are a step toward a cleaner bioproduction process with less waste, helping our customers achieve their sustainability goals.”

Thermo Fisher’s innovations and initiatives reflect its commitment to driving sustainability in solving the world’s most challenging medical issues. The company is innovating greener products across five key areas: minimizing hazardous materials, reducing waste and resource use, increasing energy efficiency, responsible packaging and shipping, and extending product lifespans. Thermo Fisher’s Design for Sustainability principles guide product design, creating more sustainable options in its Greener by Design™ portfolio to advance sustainability and improve lab safety.

Events & Webinars